A Comparison of Lysosomal Enzymes Expression Levels in Peripheral Blood of Mild- and Severe-Alzheimer’s Disease and MCI Patients: Implications for Regenerative Medicine Approaches
暂无分享,去创建一个
N. Smania | F. Schena | C. Emiliani | F. Morena | S. Martino | A. Di Baldassarre | R. Calafiore | M. Venturelli | Chiara Argentati | F. Naro | Anna Pedrinolla | G. Basta | P. Montanucci | M. Rende | A. Pistilli | A. Stabile | L. Crispoltoni | R. Trotta | A. Pedrinolla
[1] O. Tillement,et al. Multimodal imaging Gd-nanoparticles functionalized with Pittsburgh compound B or a nanobody for amyloid plaques targeting. , 2017, Nanomedicine.
[2] J. Hodges. Is pathology-specific diagnosis of the dementia possible in life? , 2017, Journal of Neurology, Neurosurgery, and Psychiatry.
[3] Bin Deng,et al. Multivariate multi-scale weighted permutation entropy analysis of EEG complexity for Alzheimer’s disease , 2017, Cognitive Neurodynamics.
[4] Massimo Venturelli,et al. Resilience to Alzheimer's Disease: The Role of Physical Activity , 2017, Current Alzheimer research.
[5] P. Snyder,et al. Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic , 2017, Alzheimer's & Dementia.
[6] G. Cerulli,et al. Changes in Plasma β-NGF and Its Receptors Expression on Peripheral Blood Monocytes During Alzheimer's Disease Progression. , 2016, Journal of Alzheimer's disease : JAD.
[7] L. Chin,et al. Parkin Protects Against Misfolded SOD1 Toxicity by Promoting Its Aggresome Formation and Autophagic Clearance , 2015, Molecular Neurobiology.
[8] E. Peyrin,et al. Detecting Alzheimer's disease biomarkers: From antibodies to new bio-mimetic receptors and their application to established and emerging bioanalytical platforms - A critical review. , 2016, Analytica chimica acta.
[9] E. Westman,et al. Cerebrospinal Fluid Biomarkers for the Differential Diagnosis between Alzheimer's Disease and Frontotemporal Lobar Degeneration: Systematic Review, HSROC Analysis, and Confounding Factors. , 2016, Journal of Alzheimer's disease : JAD.
[10] K. Rhodes,et al. The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease , 2016, Nature.
[11] P. Rancoita,et al. Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial , 2016, The Lancet.
[12] A. Gritti,et al. Pervasive supply of therapeutic lysosomal enzymes in the CNS of normal and Krabbe‐affected non‐human primates by intracerebral lentiviral gene therapy , 2016, EMBO molecular medicine.
[13] A. Schapira,et al. The relationship between glucocerebrosidase mutations and Parkinson disease , 2016, Journal of neurochemistry.
[14] Lu Yang,et al. Interplay of endoplasmic reticulum stress and autophagy in neurodegenerative disorders , 2016, Autophagy.
[15] Ki-Bum Lee,et al. Nanotechnology-Based Approaches for Guiding Neural Regeneration. , 2016, Accounts of chemical research.
[16] L. Chin,et al. Parkin Protects Against Misfolded SOD1 Toxicity by Promoting Its Aggresome Formation and Autophagic Clearance , 2015, Molecular Neurobiology.
[17] Michael L Lu,et al. Altered lysosomal positioning affects lysosomal functions in a cellular model of Huntington's disease , 2015, The European journal of neuroscience.
[18] A. Vescovi,et al. The Big Bluff of Amyotrophic Lateral Sclerosis Diagnosis: The Role of Neurodegenerative Disease Mimics , 2015, Neurodegenerative Diseases.
[19] J. Debnath,et al. Autophagy at the crossroads of catabolism and anabolism , 2015, Nature Reviews Molecular Cell Biology.
[20] P. De Camilli,et al. Massive accumulation of luminal protease-deficient axonal lysosomes at Alzheimer’s disease amyloid plaques , 2015, Proceedings of the National Academy of Sciences.
[21] Yogesan Kanagasingam,et al. Innovative diagnostic tools for early detection of Alzheimer's disease , 2015, Alzheimer's & Dementia.
[22] A. Ricca,et al. Combined gene/cell therapies provide long-term and pervasive rescue of multiple pathological symptoms in a murine model of globoid cell leukodystrophy , 2015, Human molecular genetics.
[23] S. Regis,et al. Critical issues for the proper diagnosis of Metachromatic Leukodystrophy. , 2014, Gene.
[24] P. Calabresi,et al. Cerebrospinal Fluid Lysosomal Enzymes and Alpha-Synuclein in Parkinson's Disease , 2014, Movement disorders : official journal of the Movement Disorder Society.
[25] A. Gritti,et al. A new analytical bench assay for the determination of arylsulfatase a activity toward galactosyl-3-sulfate ceramide: implication for metachromatic leukodystrophy diagnosis. , 2014, Analytical chemistry.
[26] R. Nixon,et al. Lysosome and calcium dysregulation in Alzheimer's disease: partners in crime. , 2013, Biochemical Society transactions.
[27] K. Blennow,et al. Lysosomal Network Proteins as Potential Novel CSF Biomarkers for Alzheimer’s Disease , 2013, NeuroMolecular Medicine.
[28] C. von Kalle,et al. Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic Leukodystrophy , 2013, Science.
[29] R. Nixon,et al. The role of autophagy in neurodegenerative disease , 2013, Nature Medicine.
[30] Katarina Kågedal,et al. The lysosome: from waste bag to potential therapeutic target. , 2013, Journal of molecular cell biology.
[31] A. Orlacchio,et al. miR128 up-regulation correlates with impaired amyloid β(1-42) degradation in monocytes from patients with sporadic Alzheimer's disease , 2013, Neurobiology of Aging.
[32] F. Morena,et al. MicroRNAs and Molecular Mechanisms of Neurodegeneration , 2013, Genes.
[33] K. Peall,et al. Parkinsonism, dementia and glucocerebrosidase mutations , 2013, Journal of Neurology.
[34] P. Calabresi,et al. Expression of cathepsins S and D signals a distinctive biochemical trait in CD34+ hematopoietic stem cells of relapsing–remitting multiple sclerosis patients , 2013, Multiple sclerosis.
[35] P. Hiesinger,et al. Lysosomal calcium homeostasis defects, not proton pump defects, cause endo-lysosomal dysfunction in PSEN-deficient cells , 2012, The Journal of cell biology.
[36] A. Orlacchio,et al. Knock‐down of HEXA and HEXB genes correlate with the absence of the immunostimulatory function of HSC‐derived dendritic cells , 2012, Cell biochemistry and function.
[37] Yutaka Sato,et al. Primary lysosomal dysfunction causes cargo-specific deficits of axonal transport leading to Alzheimer-like neuritic dystrophy , 2011, Autophagy.
[38] Ralph A. Nixon,et al. Autophagy failure in Alzheimer's disease—locating the primary defect , 2011, Neurobiology of Disease.
[39] A. Gritti,et al. Coordinated involvement of cathepsins S, D and cystatin C in the commitment of hematopoietic stem cells to dendritic cells. , 2011, The international journal of biochemistry & cell biology.
[40] Michael I. Miller,et al. Plasma ceramides are altered in mild cognitive impairment and predict cognitive decline and hippocampal volume loss , 2010, Alzheimer's & Dementia.
[41] D. Westaway,et al. Lysosomal Proteolysis and Autophagy Require Presenilin 1 and Are Disrupted by Alzheimer-Related PS1 Mutations , 2010, Cell.
[42] Arlan Richardson,et al. Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments. , 2010, The Journal of biological chemistry.
[43] A. Orlacchio,et al. MicroRNA Implications across Neurodevelopment and Neuropathology , 2009, Journal of biomedicine & biotechnology.
[44] G. Lopez,et al. The association between mutations in the lysosomal protein glucocerebrosidase and parkinsonism , 2009, Movement disorders : official journal of the Movement Disorder Society.
[45] Roberto Tiribuzi,et al. Neural precursor cell cultures from GM2 gangliosidosis animal models recapitulate the biochemical and molecular hallmarks of the brain pathology , 2009, Journal of neurochemistry.
[46] A. Gritti,et al. Specific determination of beta-galactocerebrosidase activity via competitive inhibition of beta-galactosidase. , 2009, Clinical chemistry.
[47] Brian Spencer,et al. The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. , 2008, The Journal of clinical investigation.
[48] G. Bernardi,et al. Cathepsin D expression is decreased in Alzheimer's disease fibroblasts , 2008, Neurobiology of Aging.
[49] F. Stivala,et al. Altered plasma cytokine levels in Alzheimer's disease: correlation with the disease progression. , 2007, Immunology letters.
[50] J. Kaye,et al. Validity of the Clinical Dementia Rating Scale for the Detection and Staging of Dementia in Brazilian Patients , 2007, Alzheimer disease and associated disorders.
[51] L. Mucke,et al. Antiamyloidogenic and Neuroprotective Functions of Cathepsin B: Implications for Alzheimer's Disease , 2006, Neuron.
[52] Federico Gallo,et al. Regulating secretory lysosomes. , 2006, Journal of biochemistry.
[53] A. Consiglio,et al. Expression and purification of a human, soluble Arylsulfatase A for Metachromatic Leukodystrophy enzyme replacement therapy. , 2005, Journal of biotechnology.
[54] G. Bernardi,et al. Up-regulation of Glycohydrolases in Alzheimer's Disease Fibroblasts Correlates with Ras Activation* , 2003, Journal of Biological Chemistry.
[55] A. Orlacchio,et al. Absence of Metabolic Cross-correction in Tay-Sachs Cells , 2002, The Journal of Biological Chemistry.
[56] A. Orlacchio,et al. β‐N‐Acetylhexosaminidase in Peripheral Blood Lymphocytes and Monocytes in the Different Forms and Stages of Multiple Sclerosis , 1998, Journal of neurochemistry.
[57] J. Morris,et al. Clinical Dementia Rating: A Reliable and Valid Diagnostic and Staging Measure for Dementia of the Alzheimer Type , 1997, International Psychogeriatrics.
[58] R. Kale. Neurodegenerative disorders , 1997, BMJ : British Medical Journal.
[59] M. Mega,et al. The Neuropsychiatric Inventory , 1994, Neurology.
[60] T. Holzman,et al. Cleavage at the amino and carboxyl termini of Alzheimer's amyloid-beta by cathepsin D. , 1994, The Journal of biological chemistry.
[61] R. Nixon,et al. Enzymatically active lysosomal proteases are associated with amyloid deposits in Alzheimer brain. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[62] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[63] S. Folstein,et al. “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician , 1975 .
[64] M. Lawton,et al. Assessment of older people: self-maintaining and instrumental activities of daily living. , 1969, The Gerontologist.
[65] D. Hwang,et al. Protein-Induced Pluripotent Stem Cells Ameliorate Cognitive Dysfunction and Reduce Aβ Deposition in a Mouse Model of Alzheimer's Disease. , 2016, Stem cells translational medicine.
[66] Wieslawa I. Mentzen,et al. Generation of Human Induced Pluripotent Stem Cell-Derived Bona Fide Neural Stem Cells for Ex Vivo Gene Therapy of Metachromatic Leukodystrophy. , 2016, Stem cells translational medicine.
[67] Simone Lista,et al. Biomarkers in Sporadic and Familial Alzheimer's Disease. , 2015, Journal of Alzheimer's disease : JAD.
[68] D. Alkon,et al. Peripheral biomarkers of Alzheimer's disease. , 2015, Journal of Alzheimer's disease : JAD.
[69] P. Calabresi,et al. Abnormal cortical lysosomal β-hexosaminidase and β-galactosidase activity at post-synaptic sites during Alzheimer's disease progression. , 2015, The international journal of biochemistry & cell biology.
[70] G. Bernardi,et al. Lysosomal β-galactosidase and β-hexosaminidase activities correlate with clinical stages of dementia associated with Alzheimer's disease and type 2 diabetes mellitus. , 2011, Journal of Alzheimer's disease : JAD.
[71] M. Ohno,et al. Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer's disease ameliorates amyloid pathologies and memory deficits. , 2011, Brain : a journal of neurology.
[72] D. Selkoe. Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.
[73] J. Wands,et al. Ceramide-mediated insulin resistance and impairment of cognitive-motor functions. , 2010, Journal of Alzheimer's disease : JAD.